The need of higher CPAP pressure in a population with obstructive sleep apnea (OSA) and refractory hypertension (RHT) versus controlled hypertension-a retrospective study

O. C. Deleanu, A. E. Malaut, S. Mihaicuta, R. Ulmeanu, F. D. Mihaltan (Bucharest, Timisoara, Romania)

Source: Annual Congress 2012 - Metabolic and cardiovascular consequences of OSA I
Session: Metabolic and cardiovascular consequences of OSA I
Session type: Thematic Poster Session
Number: 3812
Disease area: Sleep and breathing disorders

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
O. C. Deleanu, A. E. Malaut, S. Mihaicuta, R. Ulmeanu, F. D. Mihaltan (Bucharest, Timisoara, Romania). The need of higher CPAP pressure in a population with obstructive sleep apnea (OSA) and refractory hypertension (RHT) versus controlled hypertension-a retrospective study. Eur Respir J 2012; 40: Suppl. 56, 3812

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
CPAP treatment reduce blood pressure in patients with recent diagnosis of systemic hypertension and obstructive sleep apnoea -hypopnoea (OSAH). A controlled study
Source: Annual Congress 2008 - Clinical aspects of continuous positive airway pressure therapy
Year: 2008


Predictive factors for stopping use of continuous positive airway pressure (CPAP): an observational cohort of 6938 treated obstructive sleep apnea syndrome (OSAS) patients
Source: Annual Congress 2007 - Treatment options in obstructive sleep apnoea
Year: 2007


Comparative study of a novel positive airway pressure therapy versus conventional AutoCPAP therapy in obstructive sleep apnea syndrome (OSA)
Source: Eur Respir J 2005; 26: Suppl. 49, 112s
Year: 2005

Recent weight history in patients with obstructive sleep apnea syndrome (OSAS) prior to continuous positive airway pressure (CPAP) therapy
Source: Eur Respir J 2006; 28: Suppl. 50, 648s
Year: 2006

Association between obstructive sleep apnoea (OSA) and risk of systemic hypertension in men. A prospective study
Source: Eur Respir J 2003; 22: Suppl. 45, 22s
Year: 2003

Importance of controlled blood pressure values in a population with obstructive sleep apnea syndrome (OSA) and arterial hypertension (HT)
Source: Annual Congress 2011 - Cardiometabolic and neurocognitive changes in obstructive sleep apnoea
Year: 2011


Impact of a short rehabilitation program on fat visceral and blood pressure on patients with obstructive sleep apnea syndrome (OSAS). A randomized controlled study
Source: Annual Congress 2007 - Pulmonary rehabilitation beyond training
Year: 2007


PAI-uPA system in patients with obstructive sleep apnea syndrome (OSAS) in CPAP treatment
Source: Annual Congress 2012 - Cardiovascular disease and sleep-disordered breathing
Year: 2012

Prediction of effective continuous positive airway pressure (CPAP) in obstructive sleep apnea syndrome (OSA)
Source: Eur Respir J 2005; 26: Suppl. 49, 111s
Year: 2005

Should obstructive sleep apnoea be treated regarding the related cardiovascular risk in non sleepy patients?
Source: Annual Congress 2006 - Obstructive sleep apnoea and cardiovascular diseases
Year: 2006


Long-term efficacy of adaptive servo-ventilation (ASV) in patients with co-existing obstructive sleep apnea (OSAS) and Cheyne-stokes respiration (CSR). A randomised CPAP-controlled trial
Source: Annual Congress 2009 - Complex sleep apnoea and adaptive servo ventilation
Year: 2009


Effect of nCPAP on work performance (WP) in patients with obstructive sleep apnea (OSA)
Source: Eur Respir J 2005; 26: Suppl. 49, 725s
Year: 2005

A study of prevalence of sleep disordered breathing (SDB) and obstructive sleep apnea-hypopnea syndrome (OSAHS) in treated, locoregionally controlled oral cancer
Source: Annual Congress 2010 - The upper airway and oral appliances
Year: 2010


Treatment with CPAP reduces mortality in patients with obstructive sleep apnoea syndrome within less than 3 years
Source: Annual Congress 2006 - Therapeutic effects in obstructive sleep apnoea
Year: 2006


Impact of continuous positive airway pressure (CPAP) on chronic cough in obstructive sleep apnoea (OSA) – A randomized controlled trial
Source: Annual Congress 2010 - Clinical aspects of sleep apnoea
Year: 2010

Nasal resistance and CPAP compliance in a large series of obstructive sleep apnea (OSA) patients
Source: Eur Respir J 2006; 28: Suppl. 50, 408s
Year: 2006

Outcomes in patients with REM-related obstructive sleep apnoea (REM-OSA) treated with continuous positive airway pressure (CPAP)
Source: International Congress 2019 – Treatment of continuous positive airway pressure and monitoring of its effects
Year: 2019


CPAP variability in long term follow-up of OSAS (obstructive sleep apnea syndrome) patients
Source: Eur Respir J 2006; 28: Suppl. 50, 412s
Year: 2006

Effects of continuous positive airway pressure (CPAP) on quality of life in patients with obstructive sleep apnea syndromes (OSAS)
Source: Annual Congress 2010 - Clinical aspects of sleep apnoea
Year: 2010

Adherence predictors to positive airway pressure (PAP) treatment in patients with obstructive sleep apnea (OSA).
Source: Virtual Congress 2020 – Pathophysiology and treatment of obstructive sleep apnoea
Year: 2020